EP1441701 - MONTELUKAST GRANULE FORMULATION [Right-click to bookmark this link] | Status | Patent revoked Status updated on 18.12.2015 Database last updated on 19.07.2024 | Most recent event Tooltip | 08.01.2016 | Lapse of the patent in a contracting state New state(s): CH, LI | published on 10.02.2016 [2016/06] | Applicant(s) | For all designated states Merck Frosst Canada Ltd. 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | [2006/40] |
Former [2004/32] | For all designated states MERCK FROSST CANADA & CO. 16711 Trans Canada Highway Kirkland, Quebec H9H 3L1 / CA | Inventor(s) | 01 /
DOWN, Brian 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | [2004/32] | Representative(s) | Buchan, Gavin MacNicol, et al Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | [N/P] |
Former [2006/48] | Buchan, Gavin MacNicol, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB | ||
Former [2004/32] | Buchan, Gavin MacNicol Merck & Co., Inc., European Patent Department, Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 02801836.4 | 22.10.2002 | [2004/32] | WO2002CA01604 | Priority number, date | US20010339549P | 26.10.2001 Original published format: US 339549 P | [2004/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03035036 | Date: | 01.05.2003 | Language: | EN | [2003/18] | Type: | A1 Application with search report | No.: | EP1441701 | Date: | 04.08.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.05.2003 takes the place of the publication of the European patent application. | [2004/32] | Type: | B1 Patent specification | No.: | EP1441701 | Date: | 13.02.2008 | Language: | EN | [2008/07] | Search report(s) | International search report - published on: | EP | 01.05.2003 | Classification | IPC: | A61K9/16 | [2004/32] | CPC data not yet available | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/32] | Extension states | AL | Not yet paid | LT | 26.05.2004 | LV | 26.05.2004 | MK | Not yet paid | RO | 26.05.2004 | SI | 26.05.2004 | Title | German: | MONTELUKAST-GRANULATFORMULIERUNG | [2004/32] | English: | MONTELUKAST GRANULE FORMULATION | [2004/32] | French: | FORMULATION DE GRANULES DE MONTELUKAST | [2004/32] | Entry into regional phase | 26.05.2004 | National basic fee paid | 26.05.2004 | Designation fee(s) paid | 26.05.2004 | Examination fee paid | Examination procedure | 09.05.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 26.05.2004 | Examination requested [2004/32] | 21.11.2006 | Despatch of a communication from the examining division (Time limit: M06) | 18.05.2007 | Reply to a communication from the examining division | 06.08.2007 | Observations by third parties | 17.08.2007 | Communication of intention to grant the patent | 13.12.2007 | Fee for grant paid | 13.12.2007 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
05.11.2008
12.11.2008
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Jungfernstieg 38 20354 Hamburg / DE | [N/P] |
Former [2008/51] | |||
Opponent(s) | 01
05.11.2008
12.11.2008
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | 18.12.2008 | Invitation to proprietor to file observations on the notice of opposition | 26.06.2009 | Reply of patent proprietor to notice(s) of opposition | 19.04.2010 | Date of oral proceedings | 29.04.2010 | Despatch of minutes of oral proceedings | 06.10.2010 | Date of oral proceedings | 26.11.2010 | Despatch of minutes of oral proceedings | 26.11.2010 | Despatch of communication that the patent will be revoked | 02.02.2015 | Legal effect of revocation of patent [2016/03] | Appeal following opposition | 25.01.2011 | Appeal received No. T0207/11 | 04.04.2011 | Statement of grounds filed | 02.02.2015 | Result of appeal procedure: appeal of the proprietor withdrawn | Fees paid | Renewal fee | 06.10.2004 | Renewal fee patent year 03 | 07.10.2005 | Renewal fee patent year 04 | 05.10.2006 | Renewal fee patent year 05 | 15.10.2007 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CH | 13.02.2008 | LI | 13.02.2008 | MC | 31.10.2008 | [2016/06] |
Former [2009/25] | MC | 31.10.2008 | Cited in | International search | [A]US4177254 (COOK BRIAN [GB], et al) [A] 1-20 * abstract * * column 1, line 46 - line 52 ** column 3, line 10 - line 12 *; | [X]WO9716173 (MERCK FROSST CANADA INC [CA], et al) [X] 1 * example 1 * * page 2, line 22 - line 23 *; | [X]US6262077 (SHIH NENG-YANG [US]) [X] 1 * column 4, line 52 - line 58 * * column 6, line 28 - line 31 *; | [A]WO0151036 (PHOENIX U S A INC LAB [US], et al) [A] 1-20 * example 1 * | other | - RUDOLF VOIGT, Pharmazeutische Technologie für Studium und Beruf, BERLIN, DEUTSCHER APOTHEKER VERLAG, (2000), pages 166 - 167, XP003014907 |